Prostate Cancer (Issue 1) | Special Reports

Preventing Bone Metastases Progression in mCRPC: When is it too late?

September 22, 2015

Clinical Articles

Bone metastases in metastatic castration-resistant prostate cancer (mCRPC) can invade a range of sites in the skeleton where they precipitate a spectrum of pathological processes that increase morbidity, negatively affect quality of life, and decrease survival.